Etizolam (ETZ)
Etilaam; Etizest; Etizola; Sedekopan; Pasaden; Depas
Etizolam is a benzodiazepine analog. The etizolam molecule differs from a benzodiazepine in that the benzene ring has been replaced by a thiophene ring, making the drug a thienodiazepine. It possesses amnesic, anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. Etizolam, a thienodiazepine derivative, is absorbed fairly rapidly, with peak plasma levels achieved between 30 minutes and 2 hours. It has a mean elimination half life of about 3.5 hours. Etizolam possesses potent hypnotic properties, and is comparable with other short-acting benzodiazepines. Etizolam acts as a full agonist at the benzodiazepine receptor to produce its range of therapeutic and adverse effects. Similar to other benzodiazepines, etizolam binds non-selectively to benzodiazepine receptor subtypes.
Organism species: Pan-species (General)
- Customized Service n/a Complete Antigen of Etizolam (ETZ) Antigenic Transformation Customized Service Offer
- Customized Service n/a Monoclonal Antibody to Etizolam (ETZ) Monoclonal Antibody Customized Service Offer
- Customized Service n/a Polyclonal Antibody to Etizolam (ETZ) Polyclonal Antibody Customized Service Offer
- Customized Service n/a CLIA Kit for Etizolam (ETZ) CLIA Kit Customized Service Offer
- Customized Service n/a ELISA Kit for Etizolam (ETZ) ELISA Kit Customized Service Offer
